Please provide your email address to receive an email when new articles are posted on . Combining pegloticase with immunomodulation therapy greatly improves pegloticase response rates in patients with ...
Please provide your email address to receive an email when new articles are posted on . The points to consider advise beginning immunomodulatory therapy while diagnostic investigations continue.
Created with Figdraw. The downward arrow indicates a decrease in content. The solid arrow represents “direct action”, with a clear path of influence; the dashed arrow indicates “indirect action”, ...
Radiotherapy with concurrent Avelumab and Cetuximab as primary treatment in patients with locally advanced squamous cell carcinoma of the head and neck: A phase-IB feasibility trial in patients unfit ...
A prospective multicenter phase II study of sorafenib combined with cisplatin plus gemcitabine for the treatment of patients with advanced renal collecting duct carcinoma (NCT01762150). This is an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results